How does this substance act in our body and what are its potential benefits?
Cannabidiol (CBD) acts in the human body through its interaction with the endocannabinoid system (ECS), a cell signalling system that helps maintain homeostasis, the body’s internal balance.
Cannabidiol (CBD) is a chemical compound found in the cannabis plant. It is known for its therapeutic properties in a variety of diseases, such as epilepsy, anxiety, depression, multiple sclerosis and chronic pain. The mechanism of action of CBD at the cellular level is complex and not yet fully understood, but studies have indicated that it has effects on the endocannabinoid system (ECS) in the human body.
The ECS is a cellular communication system present in the human body and other mammals that helps maintain homeostasis, the internal balance of the body. The system is composed of two types of cannabinoid receptors, CB1 and CB2 receptors, and two types of cannabinoid ligands, endocannabinoids and phytocannabinoids.
CBD binds to CB2 receptors, which are mainly found in the immune system, which may explain its anti-inflammatory and analgesic effect. In addition, CBD may also influence other cell signalling systems, such as the serotonergic and dopaminergic systems, which may be involved in the regulation of mood and behaviour.
For example, in an animal study on rheumatoid arthritis, CBD was found to reduce inflammation and hypersensitivity in affected joints. In addition, it has been found that CBD may have anti-tumour effects in some types of cancer, although further studies are needed to fully understand the mechanism behind these effects.
What is the serotonergic and dopaminergic system?
The serotonergic and dopaminergic systems are two neurotransmitter systems in the brain that play an important role in regulating mood, behaviour and cognition.
The serotonergic system is composed of neurons that produce serotonin, a neurotransmitter responsible for regulating anxiety, mood, sleep, appetite and pain perception. Serotonin binds to serotonin receptors on cells in the brain and body, which can have a significant impact on behaviour and cognition.
The dopaminergic system, on the other hand, is made up of neurons that produce dopamine, a neurotransmitter responsible for regulating motivation, reward, pleasure and memory. Dopamine binds to dopamine receptors on cells in the brain and body, which can have a significant impact on behaviour and cognition.
Both systems are interconnected and can interact with each other to influence a wide variety of biological and psychological processes. CBD has been investigated for its ability to modulate these neurotransmitter systems and potentially improve the regulation of mood, behaviour and cognition.
How is full spectrum CBD oil absorbed into the body?
The absorption of Canalanza Laboratories full spectrum 20% CBD oil into the human body at the cellular and visceral level depends on several factors, such as the way the oil is administered, the amount of CBD present in the oil and the quality of the product.
When CBD oil is taken orally, such as in the form of drops or capsules, it must first pass through the digestive system before being absorbed into the bloodstream. CBD is lipophilic, meaning it dissolves in fats and oils, and is best absorbed when taken with high-fat foods. Once absorbed into the bloodstream, CBD travels throughout the body and can interact with the cannabinoid receptors of the endocannabinoid system in cells and tissues.
It is also possible to apply CBD oil directly to the skin in the form of a cream. In this case, CBD is absorbed through the pores and can interact with cannabinoid receptors in the skin, which can have beneficial effects on the skin and musculoskeletal system.
Once CBD has been absorbed into the body, it can interact with a variety of cell signalling systems, including the serotonergic and dopaminergic systems, and the cannabinoid receptors CB1 and CB2 of the endocannabinoid system. These systems can help regulate a variety of biological processes, including pain, inflammation, anxiety, mood and sleep.
It is important to note that CBD oil absorption can vary from person to person, and individual response to CBD may depend on factors such as dosage, product quality, and the medical condition being treated. It is recommended to speak to a healthcare professional before starting to take any CBD supplement.
What are the potential benefits of taking CBD oil on a daily basis?
Canalanza Laboratories CBD oil has been studied for its potential health benefits. However, it is important to note that the effects may vary from person to person and more research is needed to learn more about the benefits to our bodies.
Some possible benefits of taking CBD oil from Canalanza Laboratories on a daily basis are:
Pain relief: CBD has been shown to have analgesic and anti-inflammatory properties that can help relieve chronic and acute pain.
Anxiety and stress reduction: CBD may have anxiolytic and anti-depressant effects that can help reduce symptoms of anxiety and depression.
Improved sleep: CBD can help improve sleep quality and reduce sleep disorders such as insomnia.
Relief of cancer symptoms and treatment side effects: CBD can help reduce cancer-related symptoms such as pain and nausea, as well as treatment side effects such as nausea and neuropathic pain.
Reducing inflammation: CBD may have anti-inflammatory properties that can help reduce inflammation in the body.
Improved cardiovascular health: CBD can help reduce blood pressure and improve the health of the heart and circulatory system.
It is important to remember that these benefits are based on preliminary studies and more research is needed. In addition, you should always talk to a health professional before starting any CBD supplement.
- Ligando Cannabinoides: https://es.wikipedia.org/wiki/Ligando
- Cannabinoids in the management of difficult to treat pain: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
- Cannabinoids in the treatment of epilepsy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
- Cannabidiol in inflammatory bowel diseases: a brief overview: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847120/
- Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514832/
- Cannabidiol as a potential treatment for anxiety disorders: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/
- Cannabinoids in cancer treatment: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459826/
Octavio is CEO of Canalanza Group and a chemist by profession.
He has been dedicated to the study of CBD and its applications for health for more than 20 years.
From Canalanza Laboratories he distributes his own CBD oil of controlled production.